Financial Information

Psomagen, established in 2004, is listed on KOSDAQ (Korean Securities Dealers Automated Quotations), a trading board of Korea Exchange (KRX). Below is a breakdown of its financial position and income since 2017. 

KOSDAQ: PSOMAGEN INC (950200)

Statement of Financial Position

(unit: 1,000 USD)

   2020

   2019

   2018

   Current assets

   31,394   

 9,489   

   10,558

   Non-current assets

 15,118

    14,932     

  8,345   

   Total assets

    46,512   

  24,421   

   18,903   

   Current liabilities

   8,770   

37,800   

  6,880

   Non-current liabilities

  3,512   

2,939 

  15,098   

   Total liabilities

    12,282    

    40,739  

    21,978

   Capital stock

  1,892   

  1,245  

  1,039   

   Capital surplus

  77,561   

9,580      

  3,441   

   Deficit

  (45,765)   

  (27,473)  

  (7,685)   

   Other capital

  542   

329   

  130   

   Total shareholder’s equity

    (34,230)   

    (16,319)  

    (3,075)   

Statement of Income

(unit: 1,000 USD)

   2020

   2019

   2018

   Sales

   16,106   

   17,232   

   18,972   

   COGS

   16,157   

   15,317   

   16,787   

   Gross profit

   (51)   

   1,915   

   2,185   

   Bad debt expenses

   37   

   138   

   498   

   SG&A

   8,618

   5,944   

   4,451   

   Operating profit

   (8,706)   

   (4,167)   

   (2,764)   

   Other income

60    

  –

   5

   Other expenses

  6   

   505   

  17   

   Financial income

  834   

   473   

   2,117   

   Financial expenses

   10,843   

   15,836   

   1,722   

   Equity method gain (loss)

   371   

   244

  37   

   Pre-tax profit

   (18,290)   

   (19,971)   

   (2,344)   

   Income tax

  2   

   (2)

   1   

   Net profit

   (18,292)   

   (19,789)   

   (2,345)   

Statement of Financial Position

(mn KRW)

2019

2018

2017

Current assets 10,986 12,224 16,581
Non-current assets

17,2889,66112,008
Total assets

28,274

21,886

28,590

Current liabilities

43,764

7,9669,119
Non-current liabilities

3,40317,48020,465
Total liabilities

47,167

25,44629,584
Capital stock

1,4411,2021,202
Capital surplus

11,092

3,984

3,984

Deficit

(31,808)

(8,897)

(6,181)

Other capital

381150
Total shareholder’s equity

(18,894)

(3,560)

(994)

Statement of Income

(mn KRW)

2020

2019

2018

Sales16,10617,23218,972
COGS16,15715,31716,787
Gross profit

(51)1,9152,185
Bad debt expenses

37138498
SG&A

8,618
5,9444,451
Operating profit

(8,706)

(4,167)

(2,764)
Other income

60

5

Other expenses

6

505

17

Financial income

834

4732,117
Financial expenses

10,84315,8361,722
Equity method gain (loss)

371 244

37

Pre-tax profit

(18,290)

(19,791)

(2,344)

Income tax

2

(2)1
Net profit

(18,292)

(19,789)

(2,345)